Kairos Pharma Ltd./$KAPA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Kairos Pharma Ltd.
Kairos Pharma Ltd is a clinical-stage biopharmaceutical company. The company is engaged in therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma. The product portfolio of the company consists of Pre-clinical or clinical-trial stage drug candidates, Therapeutic agents, and other technologies for treating diseases.
Ticker
$KAPA
Sector
Primary listing
AMEX
Employees
3
Headquarters
Website
KAPA Metrics
BasicAdvanced
$7.9m
-
-$0.30
-
-
Price and volume
Market cap
$7.9m
52-week high
$2.11
52-week low
$0.33
Average daily volume
122k
Financial strength
Current ratio
10.309
Quick ratio
8.527
Profitability
EBITDA (TTM)
-5.836
Management effectiveness
Return on assets (TTM)
-54.78%
Return on equity (TTM)
-93.84%
Valuation
Price to book
1.49
Price to tangible book (TTM)
1.5
Price to free cash flow (TTM)
-1.939
Free cash flow yield (TTM)
-51.58%
Free cash flow per share (TTM)
-0.191
Growth
Earnings per share change (TTM)
6.08%
3-year earnings per share growth (CAGR)
46.86%
KAPA News
AllArticlesVideos
Kapa Gold Announces the Results of Its 2026 Annual General Meeting
Newsfile Corp·2 weeks ago
Kairos Pharma Recaps Important Acquisitions and Details Plans for the Balance of 2026 in Letter to Shareholders
Business Wire·4 weeks ago
Kairos Pharma, Ltd. to Present at the LD Micro Invitational XVI
Newsfile Corp·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs